Corrigendum: Glycogen synthase kinase-3β inhibitor SB216763 promotes DNA repair in ischemic retinal neurons
Format: | Article |
---|---|
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2021-01-01
|
Series: | Neural Regeneration Research |
Online Access: | http://www.nrronline.org/article.asp?issn=1673-5374;year=2021;volume=16;issue=10;spage=1977;epage=1977;aulast= |
Similar Items
-
Glycogen synthase kinase-3β inhibitor SB216763 promotes DNA repair in ischemic retinal neurons
by: Jing Zhang, et al.
Published: (2021-01-01) -
Glycogen synthase kinase 3 (GSK3) inhibitor, SB-216763, promotes pluripotency in mouse embryonic stem cells.
by: Leslie A Kirby, et al.
Published: (2012-01-01) -
Long-lasting antidepressant action of ketamine, but not glycogen synthase kinase-3 inhibitor SB216763, in the chronic mild stress model of mice.
by: Xian-Cang Ma, et al.
Published: (2013-01-01) -
SB216763, a selective small molecule inhibitor of glycogen synthase kinase-3, improves bleomycin-induced pulmonary fibrosis via activating autophagy
by: Hong Liu, et al.
Published: (2013-07-01) -
Amaryllidaceae Alkaloids as Potential Glycogen Synthase Kinase-3β Inhibitors
by: Daniela Hulcová, et al.
Published: (2018-03-01)